DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study.
Bon G, Krasniqi E, Porru M, D'Ambrosio L, Scalera S, Maugeri-Saccà M, Di Lisa FS, Filomeno L, Arcuri T, Botticelli A, Santini D, Fabbri MA, D'Auria G, Pulito C, Blandino G, Marchiò C, Barba M, Ciliberto G, Vici P, Pizzuti L.
Bon G, et al. Among authors: pulito c.
Neoplasia. 2023 Nov;45:100937. doi: 10.1016/j.neo.2023.100937. Epub 2023 Sep 26.
Neoplasia. 2023.
PMID: 37769528
Free PMC article.